Oklo (NYSE:OKLO) Issues Quarterly Earnings Results, Misses Expectations By $0.12 EPS

Oklo (NYSE:OKLO) issued its earnings results on Friday. The company reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.16) by ($0.12), Zacks reports. The company had revenue of $1.21 million for the quarter, compared to analysts’ expectations of $0.09 million. During the same quarter last year, the business posted ($0.18) earnings per share. The firm’s quarterly revenue was up 11900.0% compared to the same quarter last year.

Here are the key takeaways from Oklo’s conference call:

• Groves reached first criticality after transitioning from a greenfield site to an operating isotope reactor in just over 11 months, according to management. Oklo said the project validated its construction, authorization, commissioning, and operating capabilities for future deployments.
• Aurora-INL advanced with DOE approval of its preliminary documented safety analysis, site mobilization, and reactor-area excavation nearing completion; the company continues to target a 2028 startup. Oklo also expanded Ohio campus execution planning through an MOU with Kiewit and continued PJM interconnection work.
• Oklo is pursuing a diversified fuel strategy spanning EBR-II material, a potential DOE plutonium allocation, Centrus commercial HALEU, and future recycling. The Centrus letter of intent could support initial core and reload needs for up to five Aurora powerhouses, although it remains subject to a definitive agreement and deliveries are expected from 2029.
• The company strengthened its vertically integrated platform through acquisitions of ARMEC and Creative Engineers, adding engineering, manufacturing, testing, and sodium-systems capabilities. Oklo also highlighted collaborations with NVIDIA, Los Alamos National Laboratory, and DOE initiatives to apply AI to fuel qualification, reactor design, and operational workflows.
• Oklo raised its 2026 guidance for operating cash use to $120 million–$150 million from $80 million–$100 million and property, plant, and equipment spending to $400 million–$500 million from $350 million–$450 million. The company ended the quarter with more than $3 billion in cash and marketable securities, but isotope revenue is not expected to begin meaningfully until potentially early 2027, primarily from the Idaho laboratory rather than Groves.

Oklo Trading Up 14.7%

NYSE:OKLO traded up $6.19 during midday trading on Friday, hitting $48.38. 22,043,558 shares of the company were exchanged, compared to its average volume of 8,689,262. The company has a fifty day simple moving average of $50.88 and a 200 day simple moving average of $60.58. Oklo has a fifty-two week low of $36.61 and a fifty-two week high of $193.84. The company has a market capitalization of $8.42 billion, a PE ratio of -57.59 and a beta of 1.17.

Trending Headlines about Oklo

Here are the key news stories impacting Oklo this week:

• Positive Sentiment: First quarterly revenue beat expectations. Oklo reported Q2 revenue of $1.21 million, far above the approximately $90,000 consensus estimate and up sharply year over year. The result provided an early indication of potential commercial activity, despite revenue remaining very small. Oklo Publishes Second Quarter 2026 Financial Results and Business Update
• Positive Sentiment: Groves reactor reached first criticality. Oklo’s Groves Isotope Test Reactor in Texas achieved a controlled, self-sustaining chain reaction at low power less than a year after groundbreaking. The DOE-authorized milestone supports initial isotope-production testing and strengthens the company’s technical and execution case for future reactor projects, including potential data-center power applications. Oklo’s Groves Reactor Achieves First Criticality in Under a Year
• Neutral Sentiment: Investors still face a long commercialization timeline. Management and market commentary indicate that meaningful power-generation revenue may not arrive until 2027–2028. Oklo’s substantial cash reserves provide funding for licensing, development and construction, but the stock’s valuation remains dependent on successful regulatory approvals and project execution. Oklo Q2 2026 Earnings Call Transcript
• Negative Sentiment: Quarterly losses were wider than expected. Oklo reported an adjusted loss of $0.28 per share versus the $0.16 consensus estimate, reflecting continued heavy development spending. The company remains unprofitable, making future financing needs and execution particularly important for shareholders. Oklo Quarterly Earnings Results
• Negative Sentiment: Insider selling remains a risk signal. Reported open-market activity over the past six months showed numerous insider sales and no purchases, including substantial sales by co-founders Jacob DeWitte and Caroline Cochran. This may weigh on sentiment, even though sales can also reflect scheduled transactions or diversification. Oklo Stock Opinions on Reactor Criticality Milestone

Insider Activity at Oklo

In other Oklo news, CEO Jacob Dewitte sold 60,000 shares of the company’s stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $52.80, for a total value of $3,168,000.00. Following the completion of the transaction, the chief executive officer owned 511,533 shares in the company, valued at $27,008,942.40. This represents a 10.50% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Richard Craig Bealmear sold 73,081 shares of the firm’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $68.42, for a total value of $5,000,202.02. Following the transaction, the chief financial officer directly owned 397,642 shares in the company, valued at approximately $27,206,665.64. The trade was a 15.53% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 483,629 shares of company stock valued at $29,855,608 over the last ninety days. Insiders own 12.70% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Wilmington Savings Fund Society FSB purchased a new stake in shares of Oklo in the third quarter valued at about $45,000. Gilpin Wealth Management LLC purchased a new position in shares of Oklo during the fourth quarter worth about $29,000. Triumph Capital Management purchased a new position in shares of Oklo during the third quarter worth about $49,000. Kemnay Advisory Services Inc. purchased a new position in shares of Oklo during the fourth quarter worth about $35,000. Finally, Litman Gregory Wealth Management LLC acquired a new position in Oklo in the 4th quarter valued at about $36,000. 85.03% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

OKLO has been the topic of a number of recent analyst reports. Weiss Ratings raised shares of Oklo from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, May 13th. Guggenheim started coverage on shares of Oklo in a research report on Thursday, June 25th. They set a “neutral” rating for the company. Barclays lowered their target price on shares of Oklo from $82.00 to $76.00 and set an “overweight” rating for the company in a research note on Wednesday, July 22nd. Citigroup raised their price target on Oklo from $73.50 to $76.00 and gave the company a “neutral” rating in a research note on Thursday, May 14th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $122.00 price target on shares of Oklo in a report on Wednesday, May 13th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, ten have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Oklo presently has an average rating of “Moderate Buy” and a consensus target price of $88.00.

Oklo Company Profile

Oklo, Inc is a California-based energy technology company specializing in the design and development of advanced nuclear microreactors. Headquartered in Fremont, the firm focuses on small modular reactor (SMR) technology that leverages fast-neutron fission and liquid-metal cooling to deliver carbon-free power. Oklo’s core objective is to bring compact, factory-built reactors online within a decade, offering a low-footprint alternative to traditional large nuclear plants.

The company’s flagship product, the Aurora microreactor, is a 1.5-megawatt electric (MWe) fast reactor cooled by a sodium alloy.